About Spondylometaphyseal dysplasia, Sedaghatian type
Spondylometaphyseal dysplasia, Sedaghatian type is a rare disease catalogued by Orphanet (ORPHA:93317). It is associated with the GPX4 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Spondylometaphyseal dysplasia, Sedaghatian type trials.
Search ClinicalTrials.gov for "Spondylometaphyseal dysplasia, Sedaghatian type" or filter by Orphanet code ORPHA:93317 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Spondylometaphyseal dysplasia, Sedaghatian type trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Spondylometaphyseal dysplasia, Sedaghatian type. Updated daily.